K
Karyopharm Therapeutics Inc. (KPTI)
NMS – Real vaqt narxi. Valyuta: USD
2.03
-0.07 (-3.33%)
Yopilishda: Aug 12, 2026, 4:00 PM EDT
2.09
+0.06 (2.96%)
Bozordan keyin: Aug 12, 2026, 4:47 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NMS – Real vaqt narxi. Valyuta: USD
2.03
-0.07 (-3.33%)
Yopilishda: Aug 12, 2026, 4:00 PM EDT
2.09
+0.06 (2.96%)
Bozordan keyin: Aug 12, 2026, 4:47 PM EDT
This stock has a consensus price target of $15.20 based on the ratings of 11 analysts. The high is $56.00 and the low is $3.00.
| Maqsad | Min. maqsadli narx | O‘rtacha maqsadli narx | Maks. maqsadli narx |
|---|---|---|---|
| Narx | $ 3 | $ 15.2 | $ 56 |
| O’zgarish | 42.18% | 620.38% | 2554.03% |
| Sana | O‘sish/pasayish potensiali | Tahlilchi firmasi | Maqsadli narx | Reyting o‘zgarishi | Reyting |
|---|---|---|---|---|---|
| 2026-07-31 | 242.3% | Piper Sandler | $16 → $7 | Maintains | Overweight |
| 2026-07-31 | 46.7% | HC Wainwright & Co. | $13 → $3 | Downgrades | Buy → Neutral |
| 2026-05-06 | 535.7% | HC Wainwright & Co. | $8 → $13 | Maintains | Buy |
| 2026-04-27 | 682.4% | Piper Sandler | $8 → $16 | Reiterates | Overweight |
| 2026-03-30 | 291.2% | Piper Sandler | $12 → $8 | Reiterates | Overweight |